$73.21 +0.43 (0.59%)
Invesco Biotechnology & Genome ETF (PBE)
Dividend History
| Pay Date | Amount | Ex-Date | Record Date |
|---|---|---|---|
| September 26, 2025 | $0.23 | 2025-09-22 | 2025-09-22 |
| June 27, 2025 | $0.13 | 2025-06-23 | 2025-06-23 |
| March 28, 2025 | $0.03 | 2025-03-24 | 2025-03-24 |
| June 28, 2024 | $0.01 | 2024-06-24 | 2024-06-24 |
| March 22, 2024 | $0.02 | 2024-03-18 | 2024-03-19 |
Dividends Summary
- Invesco Biotechnology & Genome ETF has issued 18 dividend payments over the past 16 years
- The most recent dividend was paid 28 days ago, on September 26, 2025
- The highest dividend payed out to investors during this period was $0.31 per share
- The average dividend paid during this period was $0.10 per share.
Company News
Should You Invest in the Invesco Biotechnology & Genome ETF (PBE)?
Sector ETF report for PBE
Top ETFs Tracking CRISPR Gene Editing
These exchange-traded funds track companies in this biotech space.
Weekly Market Pulse: Inflation Scare
We’re going through an inflation scare right now, and we can see the changes in markets. The recent rise in nominal bond yields is much more about inflation fears than growth hopes.
5 Top ETFs With Exposure To Biogen
For the first time in 18 years, there was a new treatment for Alzheimer’s Disease approved by the FDA. Aducanumab from Biogen Inc (NASDAQ: BIIB) was approved as a drug that can reduce the clinical decline of dementia. The FDA concluded using Aduhelm (the marketing name of Aducanumab) for Alzheimer’s patients outweighs the risk of therapy. The...